ReceptivaDx is a biochemical test designed to detect BCL6, a key marker associated with endometriosis, in endometrial biopsies. It helps identify women with unexplained infertility, failed IVF, and recurrent pregnancy loss, enabling earlier diagnosis and treatment. The test offers a high sensitivity and specificity (93% and 96% respectively) and provides a valuable tool for fertility specialists.